Int J Cardiol:光学相干断层扫描和C-反应蛋白在急性冠状动脉综合征危险分层中的应用

2019-01-20 xing.T MedSci原创

由此可见,在罪犯斑块中炎症和OCT发现的系统证据的组合确定了非常高风险的ACS。未来的研究有必要证实这些发现并在该患者亚组中测试抗炎治疗。

高C-反应蛋白(CRP)水平相关的急性冠状动脉综合征(ACS)患者表现出更高的急性缺血事件风险。然而,CRP的阳性预测值太低而无法指导特定治疗。近日,血管领域权威杂志International Journal of Cardiology上发表了一篇研究文章,研究人员旨在通过结合光学相干断层扫描(OCT)评估罪犯血管和CRP血清水平,确定可能主要受益于抗炎治疗的高风险患者亚组。

因ACS住院并接受罪犯血管的介入前OCT评估的患者均选自阿戈斯蒂诺医院OCT登记中心。该研究的主要终点是复发性ACS。CRP水平≥2mg/L被认为是异常的。

总体研究人群包含了178名患者。其中,156名患者被纳入主要终点分析。3年随访时再次发生ACS的比例为23%。高CRP(2.587,95%CI为1.345-10.325,p=0.031)、斑块破裂(3.985,95%CI为1.698-8.754,p=0.009)、巨噬细胞浸润(3.145,95%CI为1.458-9.587,p=0.012)和多灶性动脉粥样硬化(2.734,95%CI为1.748-11.875,p=0.042)是再次发生ACS的独立预测因子。所有具有较高CRP且具有所有OCT高风险特征的患者(14/14)都再次发生ACS。另一方面,82例CRP水平低且OCT缺乏高风险特征的患者中只有4例在随访时再次发生ACS。

由此可见,在罪犯斑块中炎症和OCT发现的系统证据的组合确定了非常高风险的ACS。未来的研究有必要证实这些发现并在该患者亚组中测试抗炎治疗。

原始出处:


FrancescoFracassi,et al.Optical coherence tomography and C-reactive protein in risk stratification of acute coronary syndromes.International Journal of Cardiology.2019.https://doi.org/10.1016/j.ijcard.2019.01.058

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1706855, encodeId=f5f41e068551f, content=<a href='/topic/show?id=15bd30902cc' target=_blank style='color:#2F92EE;'>#冠状动脉综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30902, encryptionId=15bd30902cc, topicName=冠状动脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=345831322662, createdName=124985dbm16(暂无昵称), createdTime=Tue Apr 02 01:44:00 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720522, encodeId=157a1e2052242, content=<a href='/topic/show?id=09bf36e741d' target=_blank style='color:#2F92EE;'>#危险分层#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36774, encryptionId=09bf36e741d, topicName=危险分层)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d5032846700, createdName=tidiq, createdTime=Thu Jun 20 06:44:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1781998, encodeId=befc1e819985b, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Thu Feb 21 09:44:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431420, encodeId=4817143142014, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575046, encodeId=9c4115e5046fc, content=<a href='/topic/show?id=b265388684' target=_blank style='color:#2F92EE;'>#C-反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3886, encryptionId=b265388684, topicName=C-反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8416056084, createdName=szhvet, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585858, encodeId=c24e158585835, content=<a href='/topic/show?id=326a28e723e' target=_blank style='color:#2F92EE;'>#光学相干断层扫描#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28772, encryptionId=326a28e723e, topicName=光学相干断层扫描)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba7f17300642, createdName=yyanpro@27cn.c, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358709, encodeId=8e70358e090c, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Jan 20 13:54:23 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1706855, encodeId=f5f41e068551f, content=<a href='/topic/show?id=15bd30902cc' target=_blank style='color:#2F92EE;'>#冠状动脉综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30902, encryptionId=15bd30902cc, topicName=冠状动脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=345831322662, createdName=124985dbm16(暂无昵称), createdTime=Tue Apr 02 01:44:00 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720522, encodeId=157a1e2052242, content=<a href='/topic/show?id=09bf36e741d' target=_blank style='color:#2F92EE;'>#危险分层#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36774, encryptionId=09bf36e741d, topicName=危险分层)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d5032846700, createdName=tidiq, createdTime=Thu Jun 20 06:44:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1781998, encodeId=befc1e819985b, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Thu Feb 21 09:44:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431420, encodeId=4817143142014, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575046, encodeId=9c4115e5046fc, content=<a href='/topic/show?id=b265388684' target=_blank style='color:#2F92EE;'>#C-反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3886, encryptionId=b265388684, topicName=C-反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8416056084, createdName=szhvet, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585858, encodeId=c24e158585835, content=<a href='/topic/show?id=326a28e723e' target=_blank style='color:#2F92EE;'>#光学相干断层扫描#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28772, encryptionId=326a28e723e, topicName=光学相干断层扫描)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba7f17300642, createdName=yyanpro@27cn.c, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358709, encodeId=8e70358e090c, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Jan 20 13:54:23 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1706855, encodeId=f5f41e068551f, content=<a href='/topic/show?id=15bd30902cc' target=_blank style='color:#2F92EE;'>#冠状动脉综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30902, encryptionId=15bd30902cc, topicName=冠状动脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=345831322662, createdName=124985dbm16(暂无昵称), createdTime=Tue Apr 02 01:44:00 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720522, encodeId=157a1e2052242, content=<a href='/topic/show?id=09bf36e741d' target=_blank style='color:#2F92EE;'>#危险分层#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36774, encryptionId=09bf36e741d, topicName=危险分层)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d5032846700, createdName=tidiq, createdTime=Thu Jun 20 06:44:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1781998, encodeId=befc1e819985b, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Thu Feb 21 09:44:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431420, encodeId=4817143142014, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575046, encodeId=9c4115e5046fc, content=<a href='/topic/show?id=b265388684' target=_blank style='color:#2F92EE;'>#C-反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3886, encryptionId=b265388684, topicName=C-反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8416056084, createdName=szhvet, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585858, encodeId=c24e158585835, content=<a href='/topic/show?id=326a28e723e' target=_blank style='color:#2F92EE;'>#光学相干断层扫描#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28772, encryptionId=326a28e723e, topicName=光学相干断层扫描)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba7f17300642, createdName=yyanpro@27cn.c, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358709, encodeId=8e70358e090c, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Jan 20 13:54:23 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1706855, encodeId=f5f41e068551f, content=<a href='/topic/show?id=15bd30902cc' target=_blank style='color:#2F92EE;'>#冠状动脉综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30902, encryptionId=15bd30902cc, topicName=冠状动脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=345831322662, createdName=124985dbm16(暂无昵称), createdTime=Tue Apr 02 01:44:00 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720522, encodeId=157a1e2052242, content=<a href='/topic/show?id=09bf36e741d' target=_blank style='color:#2F92EE;'>#危险分层#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36774, encryptionId=09bf36e741d, topicName=危险分层)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d5032846700, createdName=tidiq, createdTime=Thu Jun 20 06:44:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1781998, encodeId=befc1e819985b, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Thu Feb 21 09:44:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431420, encodeId=4817143142014, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575046, encodeId=9c4115e5046fc, content=<a href='/topic/show?id=b265388684' target=_blank style='color:#2F92EE;'>#C-反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3886, encryptionId=b265388684, topicName=C-反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8416056084, createdName=szhvet, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585858, encodeId=c24e158585835, content=<a href='/topic/show?id=326a28e723e' target=_blank style='color:#2F92EE;'>#光学相干断层扫描#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28772, encryptionId=326a28e723e, topicName=光学相干断层扫描)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba7f17300642, createdName=yyanpro@27cn.c, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358709, encodeId=8e70358e090c, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Jan 20 13:54:23 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
    2019-01-22 zhouqu_8
  5. [GetPortalCommentsPageByObjectIdResponse(id=1706855, encodeId=f5f41e068551f, content=<a href='/topic/show?id=15bd30902cc' target=_blank style='color:#2F92EE;'>#冠状动脉综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30902, encryptionId=15bd30902cc, topicName=冠状动脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=345831322662, createdName=124985dbm16(暂无昵称), createdTime=Tue Apr 02 01:44:00 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720522, encodeId=157a1e2052242, content=<a href='/topic/show?id=09bf36e741d' target=_blank style='color:#2F92EE;'>#危险分层#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36774, encryptionId=09bf36e741d, topicName=危险分层)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d5032846700, createdName=tidiq, createdTime=Thu Jun 20 06:44:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1781998, encodeId=befc1e819985b, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Thu Feb 21 09:44:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431420, encodeId=4817143142014, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575046, encodeId=9c4115e5046fc, content=<a href='/topic/show?id=b265388684' target=_blank style='color:#2F92EE;'>#C-反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3886, encryptionId=b265388684, topicName=C-反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8416056084, createdName=szhvet, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585858, encodeId=c24e158585835, content=<a href='/topic/show?id=326a28e723e' target=_blank style='color:#2F92EE;'>#光学相干断层扫描#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28772, encryptionId=326a28e723e, topicName=光学相干断层扫描)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba7f17300642, createdName=yyanpro@27cn.c, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358709, encodeId=8e70358e090c, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Jan 20 13:54:23 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1706855, encodeId=f5f41e068551f, content=<a href='/topic/show?id=15bd30902cc' target=_blank style='color:#2F92EE;'>#冠状动脉综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30902, encryptionId=15bd30902cc, topicName=冠状动脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=345831322662, createdName=124985dbm16(暂无昵称), createdTime=Tue Apr 02 01:44:00 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720522, encodeId=157a1e2052242, content=<a href='/topic/show?id=09bf36e741d' target=_blank style='color:#2F92EE;'>#危险分层#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36774, encryptionId=09bf36e741d, topicName=危险分层)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d5032846700, createdName=tidiq, createdTime=Thu Jun 20 06:44:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1781998, encodeId=befc1e819985b, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Thu Feb 21 09:44:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431420, encodeId=4817143142014, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575046, encodeId=9c4115e5046fc, content=<a href='/topic/show?id=b265388684' target=_blank style='color:#2F92EE;'>#C-反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3886, encryptionId=b265388684, topicName=C-反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8416056084, createdName=szhvet, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585858, encodeId=c24e158585835, content=<a href='/topic/show?id=326a28e723e' target=_blank style='color:#2F92EE;'>#光学相干断层扫描#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28772, encryptionId=326a28e723e, topicName=光学相干断层扫描)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba7f17300642, createdName=yyanpro@27cn.c, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358709, encodeId=8e70358e090c, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Jan 20 13:54:23 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1706855, encodeId=f5f41e068551f, content=<a href='/topic/show?id=15bd30902cc' target=_blank style='color:#2F92EE;'>#冠状动脉综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30902, encryptionId=15bd30902cc, topicName=冠状动脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=345831322662, createdName=124985dbm16(暂无昵称), createdTime=Tue Apr 02 01:44:00 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720522, encodeId=157a1e2052242, content=<a href='/topic/show?id=09bf36e741d' target=_blank style='color:#2F92EE;'>#危险分层#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36774, encryptionId=09bf36e741d, topicName=危险分层)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d5032846700, createdName=tidiq, createdTime=Thu Jun 20 06:44:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1781998, encodeId=befc1e819985b, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Thu Feb 21 09:44:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431420, encodeId=4817143142014, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575046, encodeId=9c4115e5046fc, content=<a href='/topic/show?id=b265388684' target=_blank style='color:#2F92EE;'>#C-反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3886, encryptionId=b265388684, topicName=C-反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8416056084, createdName=szhvet, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585858, encodeId=c24e158585835, content=<a href='/topic/show?id=326a28e723e' target=_blank style='color:#2F92EE;'>#光学相干断层扫描#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28772, encryptionId=326a28e723e, topicName=光学相干断层扫描)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba7f17300642, createdName=yyanpro@27cn.c, createdTime=Tue Jan 22 04:44:00 CST 2019, time=2019-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358709, encodeId=8e70358e090c, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Jan 20 13:54:23 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
    2019-01-20 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

相关资讯

JACC Cardiovasc Inte:OCT定义的易损斑块与功能性狭窄程度及微血管障碍相关

众所周知,心外膜病变及微血管功能障碍的严重程度均与不良临床结局具有相关性。JACC:Cardiovascular Interventions发表的一项最新研究探讨不稳定斑块特征与生理病变严重程度及微血管功能障碍的相关性。

PLoS One:OCT血管造影术的定量和可重复临床应用研究

法国里昂大学中心住医院眼科的Douma I近日在PLoS One发表了一篇文章,他们针对OCT-A的操作,提出了一种可重复和更加精确的方法,促进临床上定量使用OCT-A。

J AAPOS:弱视儿童的OCT血管造影结果

葡萄牙科英布拉大学中心眼科学系的Sobral I近日在J AAPOS发表一项重要工作,他们使用光学相干断层扫描血管造影术(OCT-A),比较了对侧眼儿童和健康儿童在弱视眼的微观结构和血管分布方面的差异。

JACC:OCT vs. 血管造影指导的PCI

血管造影指导的经皮冠状动脉介入治疗(PCI)具有一定局限性,迄今为止有关其对临床终点影响的数据有限,但光学相干断层扫描(OCT)的空间分辨率优势可转化为有意义的临床获益。JACC发表的一项最新研究探讨了在PCI时使用OCT对患者长期生存的影响。

Methods Mol Biol:用OCT进行小鼠表型分析

德国Tuebingen大学眼科医院眼科中心的Ochakovski GA等人近日在Methods Mol Biol杂志上发表一篇重要的工作,他们详细介绍了使用光学相干断层扫描(OCT)在小鼠中的应用。

CHC2018丨贾海波教授:OCT对斑块破裂的判定及临床意义

斑块破裂(plaque rupture)是急性心肌梗死发病的高风险因素之一,光学相干断层成像(OCT)技术可识别斑块特征,指导治疗。近日,在CHC 2018学术大会上,哈尔滨医科大学附属第二医院贾海波教授就相关专题发表精彩报告。